Literature DB >> 19229505

GRK mythology: G-protein receptor kinases in cardiovascular disease.

Gerald W Dorn1.   

Abstract

G-protein receptor kinases (GRKs) are indispensable for terminating signaling of G-protein coupled receptors (GPCR) through receptor desensitization and downregulation. Increased neurohormone levels in heart failure and the adverse consequences of constant neurohormonal stimulation suggest an important protective role for mechanisms that desensitize neurohormone receptor responses. For that reason, GRK2, the first GRK identified in the heart, has been extensively studied in heart failure, cardiac hypertrophy, and myocardial infarction. However, our understanding of the roles of GRKs in general, and the differential effects of cardiac receptor phosphorylation by individual cardiac-expressed GRKs, have evolved considerably in the last few years. Here, recent developments are reviewed, with an emphasis on novel GRK functions and signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19229505     DOI: 10.1007/s00109-009-0450-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  71 in total

1.  Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.

Authors:  D C White; J A Hata; A S Shah; D D Glower; R J Lefkowitz; W J Koch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.

Authors:  A S Shah; D C White; S Emani; A P Kypson; R E Lilly; K Wilson; D D Glower; R J Lefkowitz; W J Koch
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

Review 3.  Beta-adrenergic function in heart muscle disease and heart failure.

Authors:  M R Bristow; N E Kantrowitz; R Ginsburg; M B Fowler
Journal:  J Mol Cell Cardiol       Date:  1985-07       Impact factor: 5.000

4.  M opsin phosphorylation in intact mammalian retinas.

Authors:  Peng Liu; Shoji Osawa; Ellen R Weiss
Journal:  J Neurochem       Date:  2005-04       Impact factor: 5.372

5.  Expression of a beta-adrenergic receptor kinase inhibitor reverses dysfunction in failing cardiomyocytes.

Authors:  Andrea D Eckhart; Walter J Koch
Journal:  Mol Ther       Date:  2002-01       Impact factor: 11.454

6.  Selective regulation of Galpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2.

Authors:  C V Carman; J L Parent; P W Day; A N Pronin; P M Sternweis; P B Wedegaertner; A G Gilman; J L Benovic; T Kozasa
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

7.  Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling.

Authors:  Scot J Matkovich; Abhinav Diwan; Justin L Klanke; Daniel J Hammer; Yehia Marreez; Amy M Odley; Eric W Brunskill; Walter J Koch; Robert J Schwartz; Gerald W Dorn
Journal:  Circ Res       Date:  2006-09-28       Impact factor: 17.367

8.  The structure of G protein-coupled receptor kinase (GRK)-6 defines a second lineage of GRKs.

Authors:  David T Lodowski; Valerie M Tesmer; Jeffrey L Benovic; John J G Tesmer
Journal:  J Biol Chem       Date:  2006-04-13       Impact factor: 5.157

9.  Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases.

Authors:  R T Premont; W J Koch; J Inglese; R J Lefkowitz
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

10.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors.

Authors:  H Daub; F U Weiss; C Wallasch; A Ullrich
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

View more
  39 in total

Review 1.  Regulation of β-adrenergic receptor function: an emphasis on receptor resensitization.

Authors:  Neelakantan T Vasudevan; Maradumane L Mohan; Shyamal K Goswami; Sathyamangla V Naga Prasad
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

2.  RAAS and adrenergic genes in heart failure: Function, predisposition and survival implications.

Authors:  Alberto J Alves; Nir Eynon; José Oliveira; Ehud Goldhammer
Journal:  World J Cardiol       Date:  2010-07-26

3.  Molecular basis for activation of G protein-coupled receptor kinases.

Authors:  Cassandra A Boguth; Puja Singh; Chih-chin Huang; John J G Tesmer
Journal:  EMBO J       Date:  2010-08-20       Impact factor: 11.598

4.  Molecular mechanism for inhibition of g protein-coupled receptor kinase 2 by a selective RNA aptamer.

Authors:  Valerie M Tesmer; Sabine Lennarz; Günter Mayer; John J G Tesmer
Journal:  Structure       Date:  2012-06-21       Impact factor: 5.006

Review 5.  Targeted gene therapy for the treatment of heart failure.

Authors:  Kleopatra Rapti; Antoine H Chaanine; Roger J Hajjar
Journal:  Can J Cardiol       Date:  2011 May-Jun       Impact factor: 5.223

6.  Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors.

Authors:  David M Thal; Raymond Y Yeow; Christian Schoenau; Jochen Huber; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2011-05-19       Impact factor: 4.436

7.  Crystal Structure of G Protein-coupled Receptor Kinase 5 in Complex with a Rationally Designed Inhibitor.

Authors:  Kristoff T Homan; Helen V Waldschmidt; Alisa Glukhova; Alessandro Cannavo; Jianliang Song; Joseph Y Cheung; Walter J Koch; Scott D Larsen; John J G Tesmer
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

Review 8.  G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function.

Authors:  Douglas G Tilley
Journal:  Circ Res       Date:  2011-07-08       Impact factor: 17.367

Review 9.  The genomic architecture of sporadic heart failure.

Authors:  Gerald W Dorn
Journal:  Circ Res       Date:  2011-05-13       Impact factor: 17.367

10.  Overexpression of GRK6 associates with the progression and prognosis of colorectal carcinoma.

Authors:  Ran Tao; Qiang Li; Xiaofei Gao; Lilin Ma
Journal:  Oncol Lett       Date:  2018-02-12       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.